These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25188235)

  • 1. Striatal astrocytes act as a reservoir for L-DOPA.
    Asanuma M; Miyazaki I; Murakami S; Diaz-Corrales FJ; Ogawa N
    PLoS One; 2014; 9(9):e106362. PubMed ID: 25188235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.
    Conti Mazza MM; Centner A; Werner DF; Bishop C
    Brain Res; 2023 Jul; 1811():148381. PubMed ID: 37127174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.
    Mura A; Jackson D; Manley MS; Young SJ; Groves PM
    Brain Res; 1995 Dec; 704(1):51-60. PubMed ID: 8750961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
    Asanuma M; Miyazaki I
    BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation.
    Sader-Mazbar O; Loboda Y; Rabey MJ; Finberg JP
    Br J Pharmacol; 2013 Nov; 170(5):999-1013. PubMed ID: 23992249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
    Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.
    Nakamura K; Ahmed M; Barr E; Leiden JM; Kang UJ
    Cell Transplant; 2000; 9(5):567-76. PubMed ID: 11144954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
    Fonseca CP; Gama S; Saavedra A; Baltazar G
    Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D; Abercrombie ED; Zigmond MJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
    Hefti F; Melamed E
    Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.
    Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Bishop C
    Behav Brain Res; 2014 Aug; 270():75-85. PubMed ID: 24837745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats.
    Sočan V; Dolinar K; Kržan M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat.
    Orosz D; Bennett JP
    Exp Neurol; 1992 Mar; 115(3):388-93. PubMed ID: 1537396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.